Research: Access to HCV Therapy for Patients with Mental Health or Substance Use Disorders
Has Access to Hepatitis C Virus Therapy Changed for Patients with Mental Health or Substance Use Disorders In The Direct-Acting-Antiviral Period? Direct‐acting antivirals (DAA) for hepatitis C virus (HCV) became available in 2014, but the role of mental health or substance use disorders (MH/SUD) on access to treatment is unknown. Read more…